| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.075 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |